NCT01365169
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +89 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Colorectal Carcinoma
Explore clinical trials studying Recurrent Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.
17 public trials
3 recruiting studies
Recurrent Colorectal Carcinoma trial results
NCT06307548
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not yet recruiting
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683
- Conditions
- Advanced Colorectal Carcinoma, Colonic Diseases, Colorectal Neoplasms, +10 more
- Locations
-
- Wuhan Union Hospital, China Wuhan, Hubei, China
Active, not recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, not recruiting
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
NCT04616183
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +41 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
NCT04017650
- Conditions
- BRAF NP_004324.2:p.V600E, Colonic Diseases, Colonic Neoplasms, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03095781
- Conditions
- Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +27 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
NCT00545545
- Conditions
- Carcinoma, Colonic Diseases, Colorectal Neoplasms, +17 more
- Locations
-
- Medical City Makati City, Philippines
- Philippine General Hospital Manila, Philippines
NCT02188264
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +15 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States